Laurion Capital Management LP Buys Shares of 2,281 The Clorox Company (NYSE:CLX)

Laurion Capital Management LP acquired a new stake in shares of The Clorox Company (NYSE:CLX) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,281 shares of the company’s stock, valued at approximately $370,000.

A number of other large investors have also made changes to their positions in CLX. Principal Financial Group Inc. boosted its stake in shares of Clorox by 6.9% during the third quarter. Principal Financial Group Inc. now owns 151,257 shares of the company’s stock valued at $24,641,000 after acquiring an additional 9,720 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Clorox by 1.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 46,309 shares of the company’s stock valued at $7,544,000 after acquiring an additional 532 shares during the last quarter. Graypoint LLC boosted its stake in shares of Clorox by 9.5% during the fourth quarter. Graypoint LLC now owns 4,269 shares of the company’s stock valued at $693,000 after acquiring an additional 370 shares during the last quarter. Czech National Bank boosted its stake in shares of Clorox by 6.4% during the fourth quarter. Czech National Bank now owns 26,839 shares of the company’s stock valued at $4,359,000 after acquiring an additional 1,607 shares during the last quarter. Finally, Fiduciary Alliance LLC boosted its stake in shares of Clorox by 64.9% during the fourth quarter. Fiduciary Alliance LLC now owns 2,432 shares of the company’s stock valued at $395,000 after acquiring an additional 957 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of analyst reports. Morgan Stanley decreased their price objective on Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Citigroup reduced their target price on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday, April 14th. Wells Fargo & Company reduced their target price on Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Finally, UBS Group reduced their target price on Clorox from $176.00 to $154.00 and set a “neutral” rating on the stock in a research report on Thursday, April 17th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $151.23.

Clorox Stock Performance

Clorox stock opened at $134.79 on Monday. The stock’s 50-day moving average is $142.37 and its 200-day moving average is $154.03. The company has a market cap of $16.60 billion, a price-to-earnings ratio of 36.83, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.71 earnings per share. Equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were issued a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.62%. Clorox’s payout ratio is currently 87.61%.

Insider Activity at Clorox

In related news, Director Pierre R. Breber bought 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 7th. The shares were acquired at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the acquisition, the director now owns 4,000 shares in the company, valued at $546,280. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.57% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.